Skip to main content
Erschienen in: Pediatric Cardiology 1/2012

01.01.2012 | Original Article

Independent Risk Factors for Cardiac Operations in Adults With Congenital Heart Disease: A Retrospective Study of 543 Operations for 500 Patients

verfasst von: Manfred Otto Vogt, Jürgen Hörer, Sophie Grünewald, Daniela Otto, Harald Kaemmerer, Christian Schreiber, John Hess

Erschienen in: Pediatric Cardiology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Adults with congenital heart disease (CHD) are an increasing population requiring cardiac operations. To date, the perioperative risk factors for this group have not been identified. This study aimed to identify clinical, morphologic, and hemodynamic risk factors for an adverse outcome. This study retrospectively analyzed a cohort of 500 patients (ages >16 years) who underwent 543 operations between January 2004 and December 2008 at a single center. The composite end point of an adverse outcome was in-hospital death, a prolonged intensive care exceeding 4 days, or both. The composite end point was reached by 253 of the patients (50.6%). Of the 500 patients, 13 (2.6%) died within 30 days after the operation. After logistic regression analysis, the following eight items remained significant: male gender (P = 0.003; odds ratio [OR] 1.8; 95% confidence interval [CI] 1.2–2.6), cyanosis (P > 0.006; OR 3.7; 95% CI 1.5–9.4), functional class exceeding 2 (P = 0.004; OR 2.2; 95% CI 1.3–3.7), chromosomal abnormalities (P = 0.004; OR 3.3; 95% CI 1.4–7.7), impaired renal function (P = 0.019; OR 3.8; 95% CI 1.2–11.5), systemic right ventricle (RV) in a biventricular circulation (P = 0.027; OR 3.3; 95% CI 1.1–9.5), enlargement of the systemic ventricle (P = 0.011; OR 1.7; 95% CI 1.1–2.6), and operation with extracorporeal circulation (P = 0.002; OR 4.3; 95% CI 1.7–11.4). Early mortality in the current adult CHD population is low. Morbidity, however, is significant and influenced by the patients’ conditions (male gender, chromosomal abnormalities), history (cyanosis, New York Hospital Association [NYHA] class), and underlying morphology (systemic RV). This information for a large cohort of patients could help progress toward more adequate counseling for adults with a congenital heart defect.
Literatur
1.
Zurück zum Zitat Atoui R, Ma F, Langlois Y et al (2008) Risk factors for prolonged stay in the intensive care unit and on the ward after cardiac surgery. J Card Surg 23:99–106PubMedCrossRef Atoui R, Ma F, Langlois Y et al (2008) Risk factors for prolonged stay in the intensive care unit and on the ward after cardiac surgery. J Card Surg 23:99–106PubMedCrossRef
2.
Zurück zum Zitat Deanfield J, Thaulow E, Warnes C et al (2003) Management of grown-up congenital heart disease. Eur Heart J 24:1035–1084PubMedCrossRef Deanfield J, Thaulow E, Warnes C et al (2003) Management of grown-up congenital heart disease. Eur Heart J 24:1035–1084PubMedCrossRef
3.
Zurück zum Zitat Diller GP, Dimopoulos K, Okonko D et al (2005) Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 112:828–835PubMedCrossRef Diller GP, Dimopoulos K, Okonko D et al (2005) Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 112:828–835PubMedCrossRef
4.
Zurück zum Zitat Dimopoulos K, Diller GP, Koltsida E et al (2008) Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 117:2320–2328PubMedCrossRef Dimopoulos K, Diller GP, Koltsida E et al (2008) Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 117:2320–2328PubMedCrossRef
5.
Zurück zum Zitat Engelfriet P, Mulder BJ (2009) Gender differences in adult congenital heart disease. Neth Heart J 17:414–417PubMedCrossRef Engelfriet P, Mulder BJ (2009) Gender differences in adult congenital heart disease. Neth Heart J 17:414–417PubMedCrossRef
6.
Zurück zum Zitat Engelfriet P, Boersma E, Oechslin E et al (2005) The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5-year follow-up period. The euro heart survey on adult congenital heart disease. Eur Heart J 26:2325–2333PubMedCrossRef Engelfriet P, Boersma E, Oechslin E et al (2005) The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5-year follow-up period. The euro heart survey on adult congenital heart disease. Eur Heart J 26:2325–2333PubMedCrossRef
7.
Zurück zum Zitat Ettema RG, Peelen LM, Schuurmans MJ, et al (2010) Prediction models for prolonged intensive care unit stay after cardiac surgery: systematic review and validation study. Circulation 122:682–689 Ettema RG, Peelen LM, Schuurmans MJ, et al (2010) Prediction models for prolonged intensive care unit stay after cardiac surgery: systematic review and validation study. Circulation 122:682–689
8.
Zurück zum Zitat Giamberti A, Chessa M, Abella R et al (2009) Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann Thorac Surg 88:1284–1289PubMedCrossRef Giamberti A, Chessa M, Abella R et al (2009) Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann Thorac Surg 88:1284–1289PubMedCrossRef
9.
Zurück zum Zitat Hein OV, Birnbaum J, Wernecke K et al (2006) Prolonged intensive care unit stay in cardiac surgery: risk factors and long-term-survival. Ann Thorac Surg 81:880–885PubMedCrossRef Hein OV, Birnbaum J, Wernecke K et al (2006) Prolonged intensive care unit stay in cardiac surgery: risk factors and long-term-survival. Ann Thorac Surg 81:880–885PubMedCrossRef
10.
Zurück zum Zitat Hoffman JI, Kaplan S, Liberthson RR (2004) Prevalence of congenital heart disease. Am Heart J 147:425–439PubMedCrossRef Hoffman JI, Kaplan S, Liberthson RR (2004) Prevalence of congenital heart disease. Am Heart J 147:425–439PubMedCrossRef
11.
Zurück zum Zitat Horer J, Herrmann F, Schreiber C et al (2007) How well are patients doing up to 30 years after a mustard operation? Thorac Cardiovasc Surg 55:359–364PubMedCrossRef Horer J, Herrmann F, Schreiber C et al (2007) How well are patients doing up to 30 years after a mustard operation? Thorac Cardiovasc Surg 55:359–364PubMedCrossRef
12.
Zurück zum Zitat Horer J, Schreiber C, Cleuziou J et al (2009) Improvement in long-term survival after hospital discharge but not in freedom from reoperation after the change from atrial to arterial switch for transposition of the great arteries. J Thorac Cardiovasc Surg 137:347–354PubMedCrossRef Horer J, Schreiber C, Cleuziou J et al (2009) Improvement in long-term survival after hospital discharge but not in freedom from reoperation after the change from atrial to arterial switch for transposition of the great arteries. J Thorac Cardiovasc Surg 137:347–354PubMedCrossRef
13.
Zurück zum Zitat Kyburz A, Bauersfeld U, Schinzel A et al (2008) The fate of children with microdeletion 22q11.2 syndrome and congenital heart defect: clinical course and cardiac outcome. Pediatr Cardiol 29:76–83PubMedCrossRef Kyburz A, Bauersfeld U, Schinzel A et al (2008) The fate of children with microdeletion 22q11.2 syndrome and congenital heart defect: clinical course and cardiac outcome. Pediatr Cardiol 29:76–83PubMedCrossRef
14.
Zurück zum Zitat Michielon G, Marino B, Oricchio G et al (2009) Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects. J Thorac Cardiovasc Surg 138:565–570 e2PubMedCrossRef Michielon G, Marino B, Oricchio G et al (2009) Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects. J Thorac Cardiovasc Surg 138:565–570 e2PubMedCrossRef
15.
Zurück zum Zitat Moons P, Engelfriet P, Kaemmerer H et al (2006) Delivery of care for adult patients with congenital heart disease in Europe: results from the euro heart survey. Eur Heart J 27:1324–1330PubMedCrossRef Moons P, Engelfriet P, Kaemmerer H et al (2006) Delivery of care for adult patients with congenital heart disease in Europe: results from the euro heart survey. Eur Heart J 27:1324–1330PubMedCrossRef
16.
Zurück zum Zitat Padalino MA, Speggiorin S, Rizzoli G et al (2007) Midterm results of surgical intervention for congenital heart disease in adults: an Italian multicenter study. J Thorac Cardiovasc Surg 134:106–113 13e1–e9PubMedCrossRef Padalino MA, Speggiorin S, Rizzoli G et al (2007) Midterm results of surgical intervention for congenital heart disease in adults: an Italian multicenter study. J Thorac Cardiovasc Surg 134:106–113 13e1–e9PubMedCrossRef
17.
Zurück zum Zitat Price S, Jaggar SI, Jordan S et al (2007) Adult congenital heart disease: intensive care management and outcome prediction. Intensive Care Med 33:652–659PubMedCrossRef Price S, Jaggar SI, Jordan S et al (2007) Adult congenital heart disease: intensive care management and outcome prediction. Intensive Care Med 33:652–659PubMedCrossRef
18.
Zurück zum Zitat Putman LM, van Gameren M, Meijboom FJ et al (2009) Seventeen years of adult congenital heart surgery: a single-centre experience. Eur J Cardiothorac Surg 36:96–104PubMedCrossRef Putman LM, van Gameren M, Meijboom FJ et al (2009) Seventeen years of adult congenital heart surgery: a single-centre experience. Eur J Cardiothorac Surg 36:96–104PubMedCrossRef
19.
Zurück zum Zitat Rosenfeld R, Smith JM, Woods SE et al (2006) Predictors and outcomes of extended intensive care unit length of stay in patients undergoing coronary artery bypass graft surgery. J Card Surg 21:146–150PubMedCrossRef Rosenfeld R, Smith JM, Woods SE et al (2006) Predictors and outcomes of extended intensive care unit length of stay in patients undergoing coronary artery bypass graft surgery. J Card Surg 21:146–150PubMedCrossRef
20.
Zurück zum Zitat Salamonsen R, Bailey M (2008) Can ICU stay be predicted accurately enough for fast-tracking cardiac surgical patients? Crit Care Resusc 10:194–201PubMed Salamonsen R, Bailey M (2008) Can ICU stay be predicted accurately enough for fast-tracking cardiac surgical patients? Crit Care Resusc 10:194–201PubMed
21.
Zurück zum Zitat Therrien J, Dore A, Gersony W et al (2001) CCS consensus conference 2001 update: recommendations for the management of adults with congenital heart disease, part I. Can J Cardiol 17:940–959PubMed Therrien J, Dore A, Gersony W et al (2001) CCS consensus conference 2001 update: recommendations for the management of adults with congenital heart disease, part I. Can J Cardiol 17:940–959PubMed
22.
Zurück zum Zitat Therrien J, Gatzoulis M, Graham T et al (2001) Canadian cardiovascular society consensus conference 2001 update: recommendations for the management of adults with congenital heart disease, part II. Can J Cardiol 17:1029–1050PubMed Therrien J, Gatzoulis M, Graham T et al (2001) Canadian cardiovascular society consensus conference 2001 update: recommendations for the management of adults with congenital heart disease, part II. Can J Cardiol 17:1029–1050PubMed
23.
Zurück zum Zitat Therrien J, Warnes C, Daliento L et al (2001) Canadian cardiovascular society consensus conference 2001 update: recommendations for the management of adults with congenital heart disease, part III. Can J Cardiol 17:1135–1158PubMed Therrien J, Warnes C, Daliento L et al (2001) Canadian cardiovascular society consensus conference 2001 update: recommendations for the management of adults with congenital heart disease, part III. Can J Cardiol 17:1135–1158PubMed
24.
Zurück zum Zitat Trojnarska O, Grajek S, Katarzynski S et al (2009) Predictors of mortality in adult patients with congenital heart disease. Cardiol J 16:341–347PubMed Trojnarska O, Grajek S, Katarzynski S et al (2009) Predictors of mortality in adult patients with congenital heart disease. Cardiol J 16:341–347PubMed
25.
Zurück zum Zitat Verheugt CL, Uiterwaal CS, van der Velde ET et al (2008) Gender and outcome in adult congenital heart disease. Circulation 118:26–32PubMedCrossRef Verheugt CL, Uiterwaal CS, van der Velde ET et al (2008) Gender and outcome in adult congenital heart disease. Circulation 118:26–32PubMedCrossRef
26.
Zurück zum Zitat Verheugt CL, Uiterwaal CS, van der Velde ET et al (2010) Mortality in adult congenital heart disease. Eur Heart J 31:1220–1229PubMedCrossRef Verheugt CL, Uiterwaal CS, van der Velde ET et al (2010) Mortality in adult congenital heart disease. Eur Heart J 31:1220–1229PubMedCrossRef
Metadaten
Titel
Independent Risk Factors for Cardiac Operations in Adults With Congenital Heart Disease: A Retrospective Study of 543 Operations for 500 Patients
verfasst von
Manfred Otto Vogt
Jürgen Hörer
Sophie Grünewald
Daniela Otto
Harald Kaemmerer
Christian Schreiber
John Hess
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 1/2012
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-011-0093-7

Weitere Artikel der Ausgabe 1/2012

Pediatric Cardiology 1/2012 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.